Legato Capital Management’s CONMED CNMD Stock Holding History

Legato Capital Management’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$290K	Sell	8,210 -6,677	-45%	-$272K	0.03%	646
2025 Q4	$604K	Sell	14,887 -7,058	-32%	-$307K	0.05%	496
2025 Q3	$1.03M	Sell	21,945 -3,271	-13%	-$170K	0.11%	283
2025 Q2	$1.31M	Sell	25,216 -4,386	-15%	-$241K	0.16%	210
2025 Q1	$1.79M	Buy	29,602 +2,202	+8%	+$142K	0.24%	122
2024 Q4	$1.88M	Buy	27,400 +7,997	+41%	+$557K	0.25%	120
2024 Q3	$1.4M	Buy	19,403 +9,530	+97%	+$672K	0.17%	206
2024 Q2	$684K	Buy	+9,873	New	+$720K	0.09%	358
2024 Q1	–	Sell	-3,735	Closed	-$409K	–	574
2023 Q4	$409K	Buy	+3,735	New	+$386K	0.05%	453
2023 Q3	–	Sell	-1,740	Closed	-$236K	–	566
2023 Q2	$236K	Buy	+1,740	New	+$212K	0.03%	505

Other funds holding CNMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

Legato Capital Management's CNMD Position: Q1 2026 in Review

Legato Capital Management reduced its CONMED (CNMD) stake by 45% in Q1 2026, selling an estimated $272K and leaving 8,210 shares worth $290K. The position accounts for 0.03% of the portfolio, ranked #646.

Legato Capital Management first reported a position in CNMD in Q2 2023 and has held it in 10 quarters since. The position peaked at $1.88M in Q4 2024. 236 funds tracked by Wall St. Rank hold CNMD as of Q1 2026.

Legato Capital Management held 8,210 shares of CONMED worth $290K as of Q1 2026.
Legato Capital Management sold 6,677 CONMED shares in Q1 2026, an estimated $272K.
CONMED made up 0.03% of Legato Capital Management's portfolio in Q1 2026, its #646 holding.
Legato Capital Management first reported a position in CONMED in Q2 2023 and has held it in 10 quarters since.
Legato Capital Management's CONMED position peaked at $1.88M in Q4 2024.
236 funds tracked by Wall St. Rank held CONMED as of Q1 2026.

Based on Legato Capital Management's 13F filing for Q1 2026, filed 14 May 2026.